549P Progression-free survival (PFS) and overall survival (OS) in patients (pts) with mismatch repair deficient (dMMR) solid tumors treated with dostarlimab in the GARNET study.
Saved in:
| Title: | 549P Progression-free survival (PFS) and overall survival (OS) in patients (pts) with mismatch repair deficient (dMMR) solid tumors treated with dostarlimab in the GARNET study. |
|---|---|
| Authors: | André, T.1 (AUTHOR), Berton-Rigaud, D.2 (AUTHOR), Curigliano, G.3 (AUTHOR), Sabatier, R.4 (AUTHOR), Tinker, A.V.5 (AUTHOR), Oaknin, A.6 (AUTHOR), De Braud, F.G.M.7 (AUTHOR), Ellard, S.8 (AUTHOR), Arkenau, H-T.9 (AUTHOR), Trigo Perez, J.M.10 (AUTHOR), Brown, J.11 (AUTHOR), Jewell, A.12 (AUTHOR), Pikiel, J.13 (AUTHOR), Mirza, M.R.14 (AUTHOR), Duan, T.15 (AUTHOR), Antony, G.16 (AUTHOR), Zildjian, S.17 (AUTHOR), Zografos, E.18 (AUTHOR), Veneris, J.17 (AUTHOR), Banerjee, S.19 (AUTHOR) |
| Source: | Annals of Oncology. 2022 Supplement 7, Vol. 33, pS799-S800. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 159077471 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 549P Progression-free survival (PFS) and overall survival (OS) in patients (pts) with mismatch repair deficient (dMMR) solid tumors treated with dostarlimab in the GARNET study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22André%2C+T%2E%22">André, T.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berton-Rigaud%2C+D%2E%22">Berton-Rigaud, D.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Curigliano%2C+G%2E%22">Curigliano, G.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sabatier%2C+R%2E%22">Sabatier, R.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tinker%2C+A%2EV%2E%22">Tinker, A.V.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Oaknin%2C+A%2E%22">Oaknin, A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22De+Braud%2C+F%2EG%2EM%2E%22">De Braud, F.G.M.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ellard%2C+S%2E%22">Ellard, S.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Arkenau%2C+H-T%2E%22">Arkenau, H-T.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Trigo+Perez%2C+J%2EM%2E%22">Trigo Perez, J.M.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brown%2C+J%2E%22">Brown, J.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jewell%2C+A%2E%22">Jewell, A.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pikiel%2C+J%2E%22">Pikiel, J.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mirza%2C+M%2ER%2E%22">Mirza, M.R.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Duan%2C+T%2E%22">Duan, T.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Antony%2C+G%2E%22">Antony, G.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zildjian%2C+S%2E%22">Zildjian, S.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zografos%2C+E%2E%22">Zografos, E.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Veneris%2C+J%2E%22">Veneris, J.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Banerjee%2C+S%2E%22">Banerjee, S.</searchLink><relatesTo>19</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2022 Supplement 7, Vol. 33, pS799-S800. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=159077471 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2022.07.677 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S799 Titles: – TitleFull: 549P Progression-free survival (PFS) and overall survival (OS) in patients (pts) with mismatch repair deficient (dMMR) solid tumors treated with dostarlimab in the GARNET study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: André, T. – PersonEntity: Name: NameFull: Berton-Rigaud, D. – PersonEntity: Name: NameFull: Curigliano, G. – PersonEntity: Name: NameFull: Sabatier, R. – PersonEntity: Name: NameFull: Tinker, A.V. – PersonEntity: Name: NameFull: Oaknin, A. – PersonEntity: Name: NameFull: De Braud, F.G.M. – PersonEntity: Name: NameFull: Ellard, S. – PersonEntity: Name: NameFull: Arkenau, H-T. – PersonEntity: Name: NameFull: Trigo Perez, J.M. – PersonEntity: Name: NameFull: Brown, J. – PersonEntity: Name: NameFull: Jewell, A. – PersonEntity: Name: NameFull: Pikiel, J. – PersonEntity: Name: NameFull: Mirza, M.R. – PersonEntity: Name: NameFull: Duan, T. – PersonEntity: Name: NameFull: Antony, G. – PersonEntity: Name: NameFull: Zildjian, S. – PersonEntity: Name: NameFull: Zografos, E. – PersonEntity: Name: NameFull: Veneris, J. – PersonEntity: Name: NameFull: Banerjee, S. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2022 Supplement 7 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 33 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
